http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2012105486-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4412 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513 |
| filingDate | 2012-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2012105486-A1 |
| titleOfInvention | A tegafur-containing composition characterized by administration once a day every other day |
| abstract | The present invention is an antitumor agent comprising a combination of tegafur, gimeracil and oteracil potassium, and when the body surface area of the patient to be administered is less than 1.25 m 2 , the amount of tegafur is 80 mg / dose, 1.25 to 1.5 m. If it is 2 100mg / dose, 1.5 m 2 or more at the 120 mg / dose in the case of, or more, once a day, 4 days every other day of the week, characterized in that it is repeatedly administered An antitumor agent is provided. |
| priorityDate | 2011-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.